VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $485,250 | -92.5% | 15,000 | -93.3% | 0.67% | -83.6% |
| Q4 2022 | $6,448,500 | +345.6% | 225,000 | +275.0% | 4.12% | +602.2% |
| Q3 2022 | $1,447,000 | -11.9% | 60,000 | 0.0% | 0.59% | +39.9% |
| Q2 2022 | $1,643,000 | -28.6% | 60,000 | 0.0% | 0.42% | -12.7% |
| Q1 2022 | $2,301,000 | -39.7% | 60,000 | -53.7% | 0.48% | +64.4% |
| Q3 2021 | $3,819,000 | -13.3% | 129,600 | 0.0% | 0.29% | +79.1% |
| Q2 2021 | $4,404,000 | -77.4% | 129,600 | -78.4% | 0.16% | -77.6% |
| Q1 2021 | $19,500,000 | -40.5% | 600,000 | +300.0% | 0.73% | -56.7% |
| Q4 2020 | $32,763,000 | +481.0% | 150,000 | +4.2% | 1.68% | +449.0% |
| Q3 2020 | $5,639,000 | +2.5% | 144,000 | -4.0% | 0.31% | +9.3% |
| Q2 2020 | $5,502,000 | -25.4% | 150,000 | -53.1% | 0.28% | -93.3% |
| Q1 2020 | $7,373,000 | +84.7% | 320,000 | +122.1% | 4.16% | +143.1% |
| Q2 2016 | $3,992,000 | – | 144,100 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |